Autism

Adaptive Research Expands into Psychiatry with Addition of Prodigy Psychiatric Group to Clinical Trial Network

SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Adaptive Research Inc. announced that Prodigy Psychiatric Group has joined its clinical…

11 months ago

Lighthouse Autism Center Announces Expansion to Indiana with Two New Centers in Hobart and La Porte

Midwest-based ABA Provider Continues Growth to Meet Increasing Demand for Autism Services Therapy Room at LAC Therapy Room at LAC…

11 months ago

A Groundbreaking Forum at HIMSS25 Focused on Behavioral Health

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- Informa Connect announces a landmark collaboration with Behavioral Health Tech to present the…

11 months ago

Stride Autism Centers Named a Winner of the 2025 Top Workplaces Award in the Great Plains

Stride Autism Centers Named a Winner of the 2025 Top Workplaces Award in the Great Plains Stride Autism Centers, a…

11 months ago

Behavioral Innovations Celebrates 25 Years of Transforming Lives Through Compassionate ABA Therapy

Honoring a Quarter Century of Dedicated Support for Children with Autism and Their Families DALLAS, TEXAS / ACCESSWIRE / January…

11 months ago

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing…

11 months ago

Clinical Trial of NeuroSigma’s Monarch eTNS System for ADHD at King’s College London Completes Enrollment

ATTENS (ADHD trial of external trigeminal nerve stimulation) Project, led by Professor Katya Rubia at the Institute of Psychiatry, Psychology…

11 months ago

RethinkFirst Appoints Ben Semmes as Chief Executive Officer

Transformational executive to lead company through the next phase of growth and innovation NEW YORK, Jan. 8, 2025 /PRNewswire/ --…

12 months ago

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

12 months ago

Beyond Air to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

GARDEN CITY, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…

12 months ago